毒性结节性甲状腺肿

  • 网络Toxic Multinodular Goiter;TMNG;Toxic Nodular Goiter
毒性结节性甲状腺肿毒性结节性甲状腺肿
  1. Graves病、继发性甲减、Graves眼病和部分非毒性结节性甲状腺肿患者TSH昼夜节律消失。

    It disappears in patiens with Graves disease , secondary hypothyroidism , Graves ophthalmopathy and a part of nontoxic nodular goitre .

  2. 方法选取21例Graves病(GD)患者、18例桥本甲状腺炎(HT)患者,17例非毒性结节性甲状腺肿(NTNG)患者,20例正常人作为对照进行研究。

    Methods 21 patients with Graves'desease ( GD ), 18 cases with Hashimoto 's thyroiditis ( HT ), 17 cases with non-toxic nodular goiter ( NTNG ) and 20 healthy subjects were enrolled in this study .

  3. ~(131)I可以有效地减小非毒性多发结节性甲状腺肿(NTMNG)病人的甲状腺体积,减轻局部压迫症状,尤其适用于有高手术危险、术后复发及拒绝手术的患者。

    I treatment for nontoxic multinodular goiter ( NTMNG ) is effective therapy to reduce the thyroid volume and to improve the local compressive symptoms , especially for the patients who are at high operative risk , have had previous thyroidectomy with goiter recurrence or refuse surgery .